We performed a comprehensive pan-cancer analysis in the Cancer Genomics Cloud of HTSeq-FPKM normalized protein coding mRNA data from 17 cancer projects in the Cancer Genome Atlas, these are Adrenal Gland, Bile Duct, Bladder, Brain, Breast, Cervix, Colorectal, Esophagus, Head and Neck, Kidney, Liver, Lung, Pancreas, Prostate, Stomach, Thyroid and Uterus. The PoTRA algorithm was applied to the normalized mRNA protein coding data and detected dysregulated pathways that can be implicated in the pathogenesis of these cancers. Then the PageRank algorithm was applied to the PoTRA results to find the most influential dysregulated pathways among all 17 cancer types. Pathways in cancer is the most common dysregulated pathway, and the MAPK signaling pathway is the most influential (PageRank score = 0.2034) while the purine metabolism pathway is the most significantly dysregulated metabolic pathway.
INTRODUCTION
Recent studies have shown that both dysregulated or frequently mutated pathways should be used for the characterization of cancers instead of driver mutations (Zhang, Chien, Yong and Kuang, 2017) . Network biology is an important approach that can detect frequently dysregulated pathways in distinct cancer types (Zhang, Chien, Yong and Kuang, 2017) . Dysregulated pathways are biological networks that have collections of hub genes that are significantly different between cancer and normal tissues. Hub genes can act individually to impact the function of other genes or entire biological networks (Flintoft, 2004) . Functional alterations in tumors have also been found to cause a cascade of alterations in pathway networks (Sanchez-Vega et al., 2018). These alterations target pathways that are advantageous for the tumors and thus avoid targeting pathways that may lead to cellular death (Sanchez-Vega et al., 2018). Identifying mRNA mediated dysregulated pathways through the analysis of large scale gene expression data has been done with TCGA data before but only with smaller numbers of cancer types that did not further consider the subtypes of these cancers or their intra-tumoral variation. In the present work, the Pathways of Topological Rank Analysis (PoTRA) algorithm was used to build correlation based gene networks from TCGA open-access data for 17 cancer types. Specifically, the PoTRA algorithm finds the correlation between each phenotypes gene expression set and the genes associated with each KEGG pathway then constructs networks for each (Li, Liu and Dinu, 2018) . Next, the dysregulated KEGG pathways with topologically ranked hub genes that are significantly different between normal and cancer are detected using Fisher's exact test (Li, Liu and Dinu, 2018) . Additionally, dysregulated KEGG pathways with significantly different distributions of PageRank scores of topologically ranked genes are also detected using the Kolmogorov-Smirnov test (Li, Liu and Dinu, 2018) . The PoTRA algorithm focuses on protein-coding messenger RNA (mRNA) mediated dysregulated pathways because mRNAs are part of the stress response at the translational level and also because they are mediators of carcinogenesis (Vaklavas, Blume and Grizzle, 2017).
Other network based methods for detecting dysregulated pathways includes multi-omics approaches where both gene mutations with high coverage and no gene overlap (single nucleotide variants, copy numbers) and gene expression data are analyzed with the Dendrix and Markov Chain Monte Carlo algorithms (Wu, Dong and Wei, 2017) . Additional approaches include using subnetworks from pathway interaction networks to detect dysregulated pathways by treating the detection as a feature selection task (Liu, Liu, Hao, Chen and Zhao, 2012). Another approach uses a combination of methylation and gene expression data with an autoencoder to identify dysregulated pathways by using the differential expression profiles of select genes (Visakh and Nazeer, 2018) .
MATERIALS AND METHODS
Google Cloud and Docker were utilized in the creation of containers for multiple data management and analysis algorithms including PoTRA. Rabix composer was utilized to match these containers with their corresponding command lines and to port the applications to the Cancer Genomics Cloud where they were implemented The applications were applied to TCGA transcriptome profiling gene expression quantification HTSeq-FPKM normalized samples (normal and tumor) from 17 primary sites. These are Adrenal Gland, Bile Duct, Bladder, Brain, Breast, Cervix, Colorectal, Esophagus, Head and Neck, Kidney, Liver, Lung, Pancreas, Prostate, Stomach, Thyroid and Uterus.
The pre-processing algorithms removes the last few lines of statistical metrics from each sample, adds a header and then comma delimits the data. The purpose of the inner join stage is to join all of the tumor and normal data by their ENSG ID. The gene conversion stage converts the ENSG ID column in the joined data set to Entrez IDs. The random resampling stage creates new balanced data sets with equal numbers of tumor and normal samples. The PoTRA algorithm "PoTRA_CorN" applies Fisher's exact and Kolmogorov-Smirnoff tests as well as calculates the number of hubs and edges to support the detection of dysregulated pathways.
It also applies the PageRank algorithm (Page et al., 1999) to determine the topological importance of each pathway gene for both normal and tumor samples. Finally, it ranks the pathways and arrives at an average rank, then averages the metrics for the hubs and edges for normal and tumor samples. Different combinations of normal and tumor were tested to determine the optimal sample sizes for both phenotypes so that the average standard deviation in the ranks of the dysregulated pathways was minimized (Linan, Wang and Dinu, 2018 ).
The KEGG database was queried to determine how much of an overlap there is between the reported dysregulated pathways for each cancer type and the dysregulated pathways that were detected and ranked by PoTRA. A literature search was performed to validate the reported dysregulated pathways. The subtypes with the least overlap between tumor groups are:
• ACC and PCPG • GBM and LGG
Dysregulated Pathways
The results of the pan-cancer analysis are a list of ranked mRNA mediated dysregulated pathways for 17 cancer types. Thus the results ( Figure 5 ) can be interpreted as how many binned The KEGG pathway known as Pathways in cancer, is the most common pathway in the Top 10 most dysregulated pathways in 11 of 17 TCGA cancer types. However, it was in the top 60 most dysregulated pathways for the Glioblastoma Multiforme and the Brain Lower Grade Glioma cancers. The MAPK signaling pathway is the most common (14 cancer projects / 17 total) and influential (PageRank score = 0.2034) among all of the significant topologically ranked dysregulated pathways for each of the 17 cancer projects ( Table 2 The second most common and influential pathways are Axon guidance and Ras signaling pathways (tie) ( Table 2 ). The Ras signaling pathway is in the top 10 most dysregulated pathways list for the following cancers: Lung Adenocarcinoma (LUAD), Lung Squamous Cell Carcinoma (LUSC), Thyroid Carcinoma (THCA), Breast Invasive Carcinoma (BRCA). The Axon guidance pathway is in the top 10 most dysregulated pathways list for the following cancers: Esophageal Carcinoma (ESCA) and Bladder Urothelial Carcinoma (BLCA).
The third most common and influential pathway is Regulation of actin cytoskeleton ( Table 2 ). The Regulation of actin cytoskeleton pathway is in the top 10 most dysregulated pathways list for the following cancers: Head and Neck Squamous Cell Carcinoma (HNSC) and Uterine Carcinosarcoma (UCS) and Uterine Corpus Endometrial Carcinoma (UCEC).
Dysregulated Signaling Pathways
In the present study, the PoTRA algorithm detected the most dysregulated signaling pathways (by rank) in the pan-cancer analysis and those are the MAPK and PI3K-Akt signaling pathway. In the literature, the RAS-MAPK signaling pathways are the most critical in cancer because of the roles they have in relevant cellular processes such as survival, differentiation and proliferation (Masliah-Planchon, Garinet and Pasmant, 2015). Interestingly, the genes in the PI3K-Akt signaling pathway are highly mutated in cancer, and when dysregulated is found to support tumorigenesis, drug resistance and cancer progression (Mayer and Arteaga, 2016) . Therefore, the frequent presence of the MAPK and PI3K-Akt signaling pathways (Table 3) PoTRA algorithm also detected this highly ranked dysregulated pathway in the aforementioned cancer types (Table 3) .
In a recent cancer study (Sikdar, Datta and Datta, 2016) , a differential network analysis identified target pathways in several cancer sets from the International Cancer Genome Consortium (ICGC). The ICGC projects included Head and Neck Squamous Cell Carcinoma (HNSC), Lung Adenocarcinoma (LUAD) and Kidney Renal Clear Cell Carcinoma (KIRC). Overall, the study concluded that the PI3K-Akt and Ras signaling pathways are the most critical for HNSC, LUAD and KIRC (Sikdar, Datta and Datta, 2016) . These results agree with the pan-cancer results (Table 3) In the present study, the PoTRA algorithm identified the Rap1 signaling pathway as the most dysregulated signaling pathway for the stomach adenocarcinoma (STAD) project. In a recent TCGA study, the KIT gene was identified as a biomarker for STAD and was also found to activate the Rap1 signaling pathway (Pan et al., 2017) . In the literature, the Rap1 signaling pathway is a key regulator of the multi-step process known as tumorigenesis, where the 3 major steps includes tumor cell migration, invasion, and metastasis . 
Dysregulated Metabolic Pathways
The purine metabolism pathway is the most significantly dysregulated metabolic pathway (by rank) in 8 out of the 17 cancer types (Table 4) . Although the purine metabolic pathway supports cellular proliferation and it is currently a therapeutic target for cancers, it's biochemical regulators are still not fully understood (Pedley and Benkovic, 2017) . However, the study of these biochemical mechanisms and how purine metabolism is dysregulated has increased the potential for new therapeutic approaches (Pedley and Benkovic, 2017) . Although the purine metabolism pathway has been a therapeutic target for several years, many of the current therapeutics suffer from toxicity and thus motivates the study of purine metabolism pathway regulation (Pedley and Benkovic, 2017) .
A recent study of dysregulated metabolic pathways in BLCA, identified the Inositol phosphate metabolism pathway as one of the most dysregulated (Rodrigues et al., 2016) . The PoTRA algorithm has also identified the Inositol phosphate metabolism pathway as one of the most dysregulated metabolic pathways for BLCA (Table 4) .
For the COAD and READ cancers, the dysregulation of the Glycerophospholipid metabolism pathway is associated with cancer cell proliferation and tumorigenesis (Yan et al., 2016) . This metabolic pathway was also identified by the PoTRA algorithm to be the most dysregulated pathway for the COAD and READ cancers (Table 4) . (Table 4) .
In another study, ACC tumors increased their production of inositol phosphate as a result of an interaction between an AT1 receptor and phosphoinositidase C in NCI-H295R human cell lines (Parmar, Kulharya and Rainey, 2010) . This finding correlates with PoTRAs identification of Inositol phosphate metabolism as the most dysregulated metabolic pathway for the ACC cancer.
For cancers such as PCPG, the mechanisms associated with the aggressiveness of this cancer are still not fully understood (Fliedner et al., 2012) . However, a previous study found that PCPG patients with succinate dehydrogenase gene (SDHx) mutations have increased levels of inositol polyphosphate phosphatase 1 in their aggressive cancer cells as well as primary high-grade tumors (Fliedner et al., 2012) . Additionally, a recent metabolites study found significantly increased levels of myoinositol in patients that were found to have SDHx mutations prior to developing PCPG (Imperiale et al., 2015) . Therefore, PoTRAs identification of the inositol phosphate metabolism pathway as the most dysregulated pathway for PCPG has biological support.
Kidney renal cell carcinoma has three subtypes known as KIRC, KICH and KIRP (Li et al., 2018) . In a recent study, the xenobiotic metabolism pathway was dysregulated in all 4 stages of the KIRC cancer (Li et al., 2018) . Previous studies have associated the dysregulation of the xenobiotic metabolism pathway with drug resistance in KIRC cancer patients (Mitsui et al., 2015; Narjoz et al., 2014). Another recent study, found that the TCGA KIRC and KIRP project gene expression data that the xenobiotic metabolism pathways are indeed enriched (Schaeffeler et al., 2018) . However, in the study, the enrichment score plot for the TCGA KICH project does not list xenobiotic metabolism as an enriched pathway (Schaeffeler et al., 2018 ).
The PoTRA algorithm identified the metabolism of xenobiotics by cytochrome P450 pathway as the most dysregulated pathway for the combined KIRC, KICH and KIRP cancers (Table 4) (Haukaas et al., 2016) . Therefore the glycerophospholipid metabolic pathway can be used to distinguish BRCA tumor subtypes (Haukaas et al., 2016) . In the present study, the glycerophospholipid metabolic pathway was identified as the most dysregulated pathway for the TCGA BRCA project.
In a recent PAAD cancer study (Halbrook and Lyssiotis, 2017) proliferating cells used glutamine as the primary source of nitrogen and carbon, it was also found to maintain redox balance Son et al., 2013) . In redox balance, glutamine derived glutamate is utilized for glutathione synthesis (Halbrook and Lyssiotis, 2017) . Another study identified glutathione as having a major role in cellular redox balance (DeBerardinis et al., 2007) . Thus, the identification of the glutathione metabolism pathways as the most dysregulated pathway for the TCGA PAAD project has biological support.
In the literature, the ESCA, GBM and LGG cancers have been reported to have dysregulated purine metabolic pathways (Zhu et al., 2017; Strickland and Stoll, 2017; Wang et al., 2017) . This agrees with the PoTRA results where purine metabolic pathway is identified as the most dysregulated pathway for the ESCA, GBM and LGG cancers ( Table 4 ).
The CHOL cancer has been reported to have the N-glycan dysregulated pathway (Varki et al, 2017) . The biosynthesis of N-glycans is upregulated to meet the metabolic needs of the cancer cells, therefore it's inhibition will result in the prevention of further tumor growth (Varki et al, 2017) . Thus, supporting PoTRAs identification of the N-Glycan pathway as the most dysregulated pathway for the CHOL cancer (Table 4 ).
In a recent study the sphingolipid metabolic pathway was reported as dysregulated in the CESC cancer (Porcari et al., 2018) . The dysregulation of the sphingolipid metabolic pathway may induce cellular processes known as apoptosis and cellular autophagy (Lizardo et al., 2017). This finding supports PoTRA's identification of the sphingolipid metabolic pathway as the most dysregulated pathway in the CESC cancer (Table 4) .
Most Highly Ranked Dysregulated Pathways
Pathways in cancer is the most common dysregulated pathway in 8 of 17 cancer types in the pan-cancer analysis, ranking in the top 10 (Table 5) Kanehisa & Goto, 2000) . Therefore, it's not surprising that multiple cancer projects were found to be associated with the pathway known as Pathways in cancer.
In the literature, the THCA cancer is associated with a dysregulated PI3K-Akt signaling pathway (Jin et al., 2013) . The dysregulated PI3K-Akt signaling pathway supports the survival response in THCA cancer cells, therefore this pathway has served as a therapeutic target multiple times (Jin et al., 2013) . This supports PoTRAs identification of this pathway as the most dysregulated for the THCA project (Table 5) .
In two recent studies, low fluid shear stress was found to induce tumor cell metastasis in cancer (Huang et al., 2018 ) and in at least one study, tumor metastasis was driven by the stimulation of the YAP1 gene, in the PRAD cancer (Lee et al., 2017) . Thus supporting PoTRA's conclusion that the fluid shear stress and atherosclerosis pathway is the most dysregulated pathway for the TCGA PRAD project (Table 5 ).
In the BLCA cancer the Autophagy -animal pathway is dysregulated to support the survival of cancer cells during metabolic stress (Chandrasekar and Evans, 2016; Chen and Karantza, 2011; Leone and Amaravadi, 2013) . Therefore, PoTRA's identification of the Autophagy -animal pathway as the most dysregulated pathway in the TCGA BLCA project (Table 5) .
In a recent TCGA study, oxidative phosphorylation is altered and targeted for inhibition in CHOL cancer (Farshidfar et al., 2017) . Thus supporting PoTRA's identification of the Vibrio Cholerae Infection pathway as the most dysregulated pathway in the TCGA CHOL project, because oxidative phosphorylation is part of the Vibrio Cholerae Infection pathway network (Table 5) .
Many cancer cells have a dysregulated Necroptosis pathway, this includes CESC cancer cells (Su et al., 2016) . Cancer cells eliminate necroptosis mechanisms and/or develop resistance against them (Su et al., 2016) . This supports PoTRA's conclusion that the Necroptosis pathway is the most dysregulated pathway in the TCGA CESC project ( Table 5 ).
The dysregulated pathways Inositol phosphate metabolism and Purine metabolism for the ACC and PCPG as well as ESCA cancers were discussed in the Dysregulated Metabolic Pathways section. The dysregulated MAPK and Ras signaling pathways for the GBM and LGG as well as PAAD cancers were discussed in the Dysregulated Signaling Pathways section.
DISCUSSION
Carcinogenesis is induced by a combination of damaging environmental stresses that includes exposures to carcinogens, UV radiation and heat shock, (NIH-NCI 2015; Sonenberg and Hinnebusch 2009) and intracellular cues such as the dysregulation of key pathway genes (Wilk and Braun, 2018) . The purpose of the PoTRA algorithm is to use Google's PageRank algorithm to find the hub genes in normal and tumor pathway networks, and to thus determine if there is truly a difference between these networks (i.e., determine if the pathway is dysregulated).
Overall, the PoTRA tool can accurately identify dysregulated pathways even in tumor samples with intratumoral heterogeneity by using a majority-rules approach. Interestingly, tumors such as those from the TCGA projects ACC, PCPG and GBM, LGG have different gene expression profiles (as seen in PCA plots) yet are still associated with the same dysregulated pathways respectively. Also, the PoTRA algorithm can identify dysregulated pathways by using only protein-coding mRNA while other algorithms arrive at similar conclusions by using a multi-omics approach. The robustness of the PoTRA algorithm (i.e., the least average standard deviation in the ranks of the detected mRNA dysregulated pathways) can be guaranteed only if the dataset is balanced and has a minimum of 50 samples per phenotype. Thus, the most consistent ranks were found for the following primary sites: Breast, Colorectal, Kidney, Liver, Lung, Prostate and Thyroid.
FUTURE DIRECTION
The PoTRA algorithm will continue to be developed so that it can utilize a more comprehensive and integrated approach to determine how that can impact the accuracy of dysregulated pathway identification. Additionally, visualizations for the graph networks will also be further developed.
CONCLUSION
The PoTRA algorithm accurately identified the dysregulated pathways associated with each TCGA cancer project. It was also easily used in the cancer genomics cloud and therefore is suited for large scale analyses.
